Allopathic and complementary alternatives to hormone replacement therapy

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 7, 2002, Pages 949-955

  Eichholz, Amy C ^a   Mahavni, Vikas ^a   Sood, Anil K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Alternatives; Complementary medicine; Hormone replacement; Menopause; Oestrogen replacement

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHAMOMILE; CHINESE DRUG; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; CONJUGATED ESTROGEN; DROLOXIFENE; ESTROGEN DERIVATIVE; FLUOXETINE; GENISTEIN; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; HYPNOTIC SEDATIVE AGENT; IDOXIFENE; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHYTOESTROGEN; PRIMROSE OIL; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN UPTAKE INHIBITOR; SOYBEAN PROTEIN; TAMOXIFEN; TOREMIFENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ESTROGEN; PLANT MEDICINAL PRODUCT;

AGING; ALTERNATIVE MEDICINE; ANGELICA SINENSIS; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN THERAPY; EXPECTATION; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; LIFESPAN; MENOPAUSAL SYNDROME; NAUSEA; PHOTOSENSITIVITY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SOYBEAN; AGED; DRUG CONTRAINDICATION; DRUG EFFECT; ECONOMICS; MENOPAUSE;

ADRENERGIC ALPHA-AGONISTS; AGED; CLONIDINE; COMPLEMENTARY THERAPIES; DIPHOSPHONATES; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, NON-STEROIDAL; FEMALE; HUMAN; MENOPAUSE; PLANT PREPARATIONS; SEROTONIN UPTAKE INHIBITORS; HUMANS; ISOFLAVONES; PHYTOESTROGENS;

EID: 0035987742     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.7.949     Document Type: Review

References (49)

1. Menopause and cognitive function; estrogens and alternative therapies
2. Hot flashes: Epidemiology and physiology
3. Effects of 'natural oestrogen' replacement therapy on menopausal symptoms and blood clotting
4. Oral medroxyprogesterone acetate in the treatment of postmenopausal symptoms
5. Objective evidence that placebo and oral medroxyprogesterone acetate diminish menopausal vasomotor flushes
6. Medical expenditures for the treatment of osteoporotic fractures in the united states in 1995: Report from the national osteoporosis foundation
7. Prophylaxis and treatment of osteoporosis
8. Bone mass and its relationship to age and the menopause
9. Relative risks and benefits of long-term estrogen replacement therapy: A decision analysis
10. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
11. Effects of hormone replacement therapy on endometrial histology in postmenopausal women
12. Cardiovascular implications of estrogen replacement therapy
13. Alternatives to estrogen replacement therapy in the menopausal patient
14. Modification of vasomotor symptoms after various treatment modalities in the postmenopause
15. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors
16. Phase III evaluation of fluoxetine for treatment of hot flashes
17. Clinical potential of new antiestrogens
18. In search of optimal long-term female hormone replacement: The potential of selective estrogen receptor modulators
19. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene results from a 3-year randomized clinical trial
20. Raloxifene and cardiovascular events in osteoporotic postmenopausal women, four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
21. Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60
22. Adverse events reported by postmenopausal women in controlled trials with raloxifene
23. Diphosphonates: History and mechanisms of action
24. Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis
25. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
26. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
27. Alternatives for women through menopause
28. FDA never promised an herb garden - But sellers and buyers eager to see new ones grow
29. Use of botanicals for management of menopausal symptoms
30. Alternative therapies for menopause
31. Hot flash relief
32. A comprehensive approach to menopause; so far, one size should fit all
33. Hormone Modulating Herbs; Implications for Women's Health
34. Estrogenic activity of two standardized red clover extracts (Menoflavon) intended for large scale use in hormone replacement therapy
35. Interaction of phytoestrogens with estrogen receptors alpha and beta
36. A review of the effectiveness of Cimicifuga Racemosa [Black Cohosh] for the symptoms of menopause
37. The effect of dietary soy supplementation on hot flushes
38. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms
39. Meta-analysis of the effects of soy protein intake on serum lipids
40. Oestrogenic effects of plant foods in postmenopausal women
41. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women
42. Dietary flour supplementation decreases post-menopausal hot flushes: Effect of soy and wheat
43. The Completed German Commission E Monographs: Therapeutic Guide To Herbal Medicines
44. Management of the climacteric
45. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing
46. A review of 12 commonly used medicinal herbs
47. Alternatives to estrogen for menopausal symptoms
48. Management of the climacteric